Bruker Expands Collaboration With Noetik to Advance Tissue Foundation Models

Reuters02-24
Bruker Expands Collaboration With Noetik to Advance Tissue Foundation Models

Bruker Spatial Biology, a division of Bruker Corporation, is expanding its collaboration with Noetik Inc. to advance tissue foundation models for translational and therapeutic applications. Building on a prior study of more than 3,500 patient samples using Bruker’s CosMx Spatial Molecular Imager, Noetik will image thousands more patients with the CosMx whole transcriptome assay to train large-scale spatial AI “world models” for oncology and drug discovery.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202602240700BIZWIRE_USPR_____20260224_BW789530) on February 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment